These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8063403

  • 1. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
    Casadevall A, DeShaw M, Fan M, Dromer F, Kozel TR, Pirofski LA.
    Infect Immun; 1994 Sep; 62(9):3864-72. PubMed ID: 8063403
    [Abstract] [Full Text] [Related]

  • 2. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.
    Nussbaum G, Anandasabapathy S, Mukherjee J, Fan M, Casadevall A, Scharff MD.
    Infect Immun; 1999 Sep; 67(9):4469-76. PubMed ID: 10456888
    [Abstract] [Full Text] [Related]

  • 3. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z.
    Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J, Kozel TR, Casadevall A.
    J Immunol; 1998 Oct 01; 161(7):3557-68. PubMed ID: 9759877
    [Abstract] [Full Text] [Related]

  • 5. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.
    Casadevall A, Scharff MD.
    J Exp Med; 1991 Jul 01; 174(1):151-60. PubMed ID: 1676047
    [Abstract] [Full Text] [Related]

  • 6. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K, Pirofski LA.
    Infect Immun; 2004 Aug 01; 72(8):4810-8. PubMed ID: 15271943
    [Abstract] [Full Text] [Related]

  • 7. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
    McFadden DC, Casadevall A.
    J Immunol; 2004 Mar 15; 172(6):3670-7. PubMed ID: 15004170
    [Abstract] [Full Text] [Related]

  • 8. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P, Nussbaum G, Oh J, Scharff MD.
    J Immunol; 1998 Aug 15; 161(4):1829-36. PubMed ID: 9712050
    [Abstract] [Full Text] [Related]

  • 9. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
    Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD.
    J Infect Dis; 1992 Jun 15; 165(6):1086-93. PubMed ID: 1583327
    [Abstract] [Full Text] [Related]

  • 10. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.
    Nakouzi A, Valadon P, Nosanchuk J, Green N, Casadevall A.
    Infect Immun; 2001 May 15; 69(5):3398-409. PubMed ID: 11292763
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.
    Mukherjee J, Casadevall A, Scharff MD.
    J Exp Med; 1993 Apr 01; 177(4):1105-16. PubMed ID: 8459205
    [Abstract] [Full Text] [Related]

  • 12. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F, Reiss E, Cherniak R, Kaufman L.
    Infect Immun; 1989 Dec 01; 57(12):3882-7. PubMed ID: 2680986
    [Abstract] [Full Text] [Related]

  • 13. Variable region gene utilization and mutation in a group of neutralizing murine anti-human immunodeficiency virus type 1 principal neutralizing determinant antibodies.
    Pirofski LA, Thomas EK, Scharff MD.
    AIDS Res Hum Retroviruses; 1993 Jan 01; 9(1):41-9. PubMed ID: 7678971
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of murine monoclonal anti-CD4. Epitope recognition, idiotype expression, and variable region gene sequence.
    Lohman KL, Attanasio R, Buck D, Carrillo MA, Allan JS, Kennedy RC.
    J Immunol; 1992 Nov 15; 149(10):3247-53. PubMed ID: 1385519
    [Abstract] [Full Text] [Related]

  • 15. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
    Beenhouwer DO, May RJ, Valadon P, Scharff MD.
    J Immunol; 2002 Dec 15; 169(12):6992-9. PubMed ID: 12471134
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
    Brandt S, Thorkildson P, Kozel TR.
    Clin Diagn Lab Immunol; 2003 Sep 15; 10(5):903-9. PubMed ID: 12965925
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W, Cherniak R, Casadevall A.
    Infect Immun; 1999 Jun 15; 67(6):3096-107. PubMed ID: 10338526
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A.
    Infect Immun; 1994 Mar 15; 62(3):1079-88. PubMed ID: 8112842
    [Abstract] [Full Text] [Related]

  • 19. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J, Scharff MD, Casadevall A.
    Infect Immun; 1995 Sep 15; 63(9):3353-9. PubMed ID: 7642262
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J, Feldmesser M, Scharff MD, Casadevall A.
    Antimicrob Agents Chemother; 1995 Jul 15; 39(7):1398-405. PubMed ID: 7492075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.